Farnesyltransferase, CAAX Box, alpha (FNTA) (N-Term) Peptide
Quick Overview for Farnesyltransferase, CAAX Box, alpha (FNTA) (N-Term) Peptide (ABIN8100455)
Target
Source
Application
-
-
Protein Region
- N-Term
-
Purpose
- FNTA Peptide - N-terminal region
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
This is a synthetic peptide designed for use in combination with anti-FNTA antibody ( ARP48520_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- FNTA (Farnesyltransferase, CAAX Box, alpha (FNTA))
-
Background
-
Targeted Subunit: alpha
Background Information: Prenyltransferases attach either a farnesyl group or a geranylgeranyl group in thioether linkage to the cysteine residue of protein's with a C-terminal CAAX box. CAAX geranylgeranyltransferase and CAAX farnesyltransferase are heterodimers that share the s
Alternative Symbols: FPTA, MGC99680, PGGT1A, PTAR2
-
Molecular Weight
- 36kDa
-
Gene ID
- 2339
-
NCBI Accession
- NP_001018197
Target
-